are compounded semaglutides going away FDA is moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Now that shortages of semaglutide

Liraglutide (Saxenda) Liraglutide requires daily injection rather than weekly, which makes site rotation even more critical

There are certain conditions where semaglutide should not be used, including decreased kidney function and acute inflammation of the pancreas

Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial

This leads to food remaining in the intestinal tract longer and, therefore, increased and prolonged feelings of satiety, or feeling full

The practical takeaway is that storage instructions are not generic suggestions

Since Medicaid will usually cover GLP-1s like Ozempic, Mounjaro, and Trulicity for the treatment of health conditions like Type 2 diabetes, you might be wondering if its possible to prescribe these off-label for weight loss and have Medicaid cover them